HomeCHRS • NASDAQ
add
Coherus Biosciences Inc
Previous close
$1.10
Day range
$1.05 - $1.15
Year range
$0.66 - $3.70
Market cap
125.58M USD
Avg Volume
2.93M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 70.77M | -5.09% |
Operating expense | 56.42M | -20.84% |
Net income | -10.75M | 72.88% |
Net profit margin | -15.19 | 71.43% |
Earnings per share | -0.01 | 96.30% |
EBITDA | -4.84M | 83.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.69M | -25.47% |
Total assets | 505.00M | -13.50% |
Total liabilities | 592.97M | -17.34% |
Total equity | -87.97M | — |
Shares outstanding | 115.21M | — |
Price to book | -1.45 | — |
Return on assets | -2.71% | — |
Return on capital | -8.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.75M | 72.88% |
Cash from operations | -62.02M | -14.21% |
Cash from investing | 444.00K | -99.12% |
Cash from financing | -167.00K | -101.50% |
Net change in cash | -61.74M | -939.87% |
Free cash flow | -39.20M | -141.03% |
About
Founded
2010
Headquarters
Website
Employees
235
